Coastal Corporation reported a strong financial performance for FY26, with consolidated revenue rising 55.7% to ₹995.3 Cr. The diversified seafood and grain ethanol company achieved a Profit After Tax (PAT) of ₹22.6 Cr, a significant increase of 387.1% compared to the previous year. This growth was driven by the operationalisation of its grain ethanol plant and sustained performance in the seafood export segment.

Consolidated Financial Performance

The company's consolidated EBITDA stood at ₹60.5 Cr with a margin of 6.23%. Revenue growth was recorded at 55.7% year-on-year. The standalone financial results also showed improvement, with revenue increasing by 13.4% to ₹707.1 Cr and standalone PAT growing by 24.3% to ₹9.6 Cr.

Segment-wise Performance

The company operates through two primary business verticals: Sea-Food and Ethanol. The Ethanol business, managed by subsidiary Coastal Biotech Pvt Ltd, started production in 2025 and has quickly become a significant revenue contributor.

Operational Updates

Coastal Biotech Private Limited, a wholly owned subsidiary, operates a grain-based ethanol plant in Odisha with an installed capacity of 198 KLPD. This facility supports India's ethanol blending program. The company also maintains a 3.6 MW captive solar power plant in Andhra Pradesh to support its sustainable energy initiatives.

The seafood segment continues to serve 12 countries across three continents. The company's manufacturing facilities include three processing units in Andhra Pradesh with a cumulative production volume of 7,506.0 MT in FY26.

Coastal Corporation reported a net profit of ₹1,350.24 lakh for the financial year ended March 31, 2026, compared to ₹739.99 lakh in the previous year. The Board of Directors recommended a final dividend of ₹0.28 per equity share of ₹2 each, translating to 14%, for FY26. The statutory auditors issued a modified opinion on the standalone financial results due to non-provision of impairment loss on an investment in a subsidiary, while the consolidated results received an unmodified opinion.

Financial Performance

Revenue from operations for the year stood at ₹70,706.05 lakh, up from ₹62,347.61 lakh in FY25. Total revenue increased to ₹70,706.05 lakh from ₹62,347.61 lakh. Total expenses for the year were ₹68,905.94 lakh compared to ₹61,319.73 lakh in the prior year. Profit before tax for FY26 was ₹1,800.11 lakh, a rise from ₹1,027.88 lakh in FY25.

Audit Qualification

Brahmayya & Co., Statutory Auditors, issued a qualified opinion on the standalone financial results. The qualification relates to Note No. 7 regarding the non-provision of an impairment loss allowance on an investment in M/s. Seacrest Seafoods Inc., a wholly owned foreign subsidiary, amounting to ₹3,009.86 lakhs as of March 31, 2026. The Board believes the investment does not suffer impairment as the subsidiary expects a substantial refund of tariffs paid to the US government based on a Supreme Court ruling. The auditors stated they are unable to express an opinion on this matter. The consolidated financial results received an unmodified opinion.

Board Decisions and Expansion

The Board approved the re-appointment of Dr. E. Sankara Rao as a Non-Executive Independent Director, subject to shareholder approval. Mr. N. S. Narayan Rao and Ms. Vineesha Valsaraj were appointed as Additional Directors in the Independent and Non-Independent categories respectively, effective May 30, 2026. Additionally, the Board approved a proposal to set up a 300 KLPD Ethanol Manufacturing Plant in Kalahandi District, Odisha, through its wholly owned subsidiary, Coastal Biotech Private Limited, at an estimated cost of ₹350 Crores.